New Potomac Partners, LLC Charles River Laboratories International, Inc. Transaction History

New Potomac Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$255.51 - $362.11 $140,530 - $199,160	-550 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$351.38 - $448.68 $52,707 - $67,302	-150 Reduced 21.43%	550 $207,000
Q3 2021 Oct 26, 2021	SELL	$372.64 - $458.3 $18,632 - $22,915	-50 Reduced 6.67%	700 $289,000
Q1 2021 Apr 29, 2021	BUY	$249.67 - $299.48 $187,252 - $224,610	750 New	750 $217,000
Q4 2020 Jan 28, 2021	SELL	$222.0 - $252.62 $166,500 - $189,465	-750 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $75,322 - $88,567	750	750 $82,000

731

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.64B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of New Potomac Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on New Potomac Partners, LLC with notifications on news.